These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2191338)

  • 1. Review of definitions and mechanisms of refractoriness to platelet transfusions.
    Hester JP; Ventura GJ
    Prog Clin Biol Res; 1990; 337():49-58. PubMed ID: 2191338
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
    Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
    Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study.
    Levin MD; de Veld JC; van der Holt B; van 't Veer MB
    Ann Hematol; 2003 Jun; 82(6):357-62. PubMed ID: 12719885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhage.
    Witzig TE; Ducatman BS; Wick MR; Letendre L; Moore SB; Ilstrup DM; Taswell HF
    Am J Hematol; 1985 Apr; 18(4):345-50. PubMed ID: 3976647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmunization following platelet transfusions in patients with acute nonlymphocytic leukemia.
    Nozaki H; Shimizu M; Komatsuda M; Watanabe K; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):201-4. PubMed ID: 3475819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
    Toor AA; Choo SY; Little JA
    Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The use of platelet transfusions.
    Feusner J
    Am J Pediatr Hematol Oncol; 1984; 6(3):255-60. PubMed ID: 6393789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet function testing to assess effectiveness of platelet transfusion therapy.
    Salama ME; Raman S; Drew MJ; Abdel-Raheem M; Mahmood MN
    Transfus Apher Sci; 2004 Apr; 30(2):93-100. PubMed ID: 15062745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombocyte substitution in hematologic patients].
    Wiesneth M
    Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose prophylactic platelet transfusions: time for further study, but too early for routine clinical practice.
    Strauss RG
    Transfusion; 2004 Dec; 44(12):1680-2. PubMed ID: 15584979
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical aspects of thrombocyte transfusion].
    Kummer H
    Beitr Infusionther Klin Ernahr; 1986; 15():156-64. PubMed ID: 3753407
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Substitution with blood coagulation factor XIII concentrates in patients with acute leukemia].
    Rasche H
    Beitr Infusionther Klin Ernahr; 1986; 15():179-86. PubMed ID: 3530242
    [No Abstract]   [Full Text] [Related]  

  • 17. A mini-review on platelet refractoriness.
    Rebulla P
    Haematologica; 2005 Feb; 90(2):247-53. PubMed ID: 15710579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombocyte collection with the cell separator. Determination of status and perspectives].
    Müller V; Borberg H
    Beitr Infusionther Klin Ernahr; 1986; 15():58-65. PubMed ID: 3753414
    [No Abstract]   [Full Text] [Related]  

  • 19. [The current status and problems associated with platelet transfusion].
    Kimura A
    Rinsho Byori; 1982 Oct; 30(10):1074-80. PubMed ID: 7182580
    [No Abstract]   [Full Text] [Related]  

  • 20. [Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia].
    Andreu G; Benbunan M; Boasson M; Bussel A; Cordonnier C; Dosquet P; Marie JP; Miclea JM; Monconduit M; Norol F
    Nouv Rev Fr Hematol (1978); 1994; 35(6):517-22. PubMed ID: 8152897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.